Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,365,673
-
Total 13F shares
-
24,542,173
-
Share change
-
+24,542,173
-
Total reported value
-
$212,355,620
-
Price per share
-
$8.87
-
Number of holders
-
50
-
Value change
-
+$212,355,924
-
Number of buys
-
50
Institutional Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) as of Q3 2020
As of 30 Sep 2020,
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,542,173 shares.
The largest 10 holders included
FMR LLC, Pentwater Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BOXER CAPITAL, LLC, Sectoral Asset Management Inc, Aisling Capital Management LP, BlackRock Inc., Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.